¿ Objective: To test the safety and efficacy of aerosolized beta-2 adrenergic agonist
therapy (Albuterol Sulfate, USP) for improving clinical outcomes in patients with acute
lung injury using a placebo controlled, double blinded randomized design.
¿ Hypothesis: Beta-2 adrenergic agonist therapy will improve clinical outcomes in
patients with acute lung injury (ALI). The potential mechanisms for improved outcomes
include a decrease in pulmonary inflammation, reduction in lung endothelial and
epithelial permeability, and enhanced resolution of alveolar edema.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
No Project Terms available.
Details
Other PIs
Not Applicable
Program Official
Name
Contact
Email not available
Organization
Name
City
Country
UNITED STATES
Department Type
Unavailable
Organization Type
Unavailable
State Code
Congressional District
Other Information
Opportunity Number
Study Section
Fiscal Year
2007
Award Notice Date
Administering Institutes or Centers
National Heart Lung and Blood Institute
CFDA Code
DUNS Number
UEI
Project Start Date
30-September-2005
Project End Date
29-September-2012
Budget Start Date
Budget End Date
Project Funding Information for 2007
Total Funding
$180,220
Direct Costs
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2007
National Heart Lung and Blood Institute
$180,220
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for N01HR56165-4-0-2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for N01HR56165-4-0-2
Patents
No Patents information available for N01HR56165-4-0-2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for N01HR56165-4-0-2
Clinical Studies
No Clinical Studies information available for N01HR56165-4-0-2
News and More
Related News Releases
No news release information available for N01HR56165-4-0-2
History
No Historical information available for N01HR56165-4-0-2
Similar Projects
No Similar Projects information available for N01HR56165-4-0-2